{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:10:06Z","timestamp":1779289806785,"version":"3.51.4"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":139,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2025-LCYJ-PY-09"],"award-info":[{"award-number":["2025-LCYJ-PY-09"]}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2025-LCYJ-MS-09"],"award-info":[{"award-number":["2025-LCYJ-MS-09"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671113"],"award-info":[{"award-number":["81671113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231120"],"award-info":[{"award-number":["BK20231120"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["ZKX22025"],"award-info":[{"award-number":["ZKX22025"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by pathogenic variants in the\n                      <jats:italic>GLA<\/jats:italic>\n                      gene and commonly involves the heart. This study aimed to investigate the pathogenicity of a novel missense variant and its amenability to migalastat.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 28 patients with FD collected over the past 10 years. Pathogenicity was assessed within a family carrying a de novo GLA missense variant through myocardial histopathology, bioinformatic predictions, protein structural modelling and in vitro cellular assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In a cohort of 28 patients (15 males, 13 females), cardiac involvement was prevalent. We further reported a family with\n                      <jats:italic>GLA<\/jats:italic>\n                      c.227T&gt;A (p.Met76Lys) variant. Myocardial biopsy showed cardiomyocyte hypertrophy with diffuse vacuolisation, interstitial fibrosis and microvascular dysfunction. Immunohistochemistry demonstrated markedly decreased expression of \u03b1-galactosidase A (\u03b1-Gal A) in vacuolated cardiomyocytes. Biochemical testing revealed low-to-normal \u03b1-Gal A enzymatic activity together with elevated plasma globotriaosylsphingosine (lyso-Gb3). Bioinformatic analyses suggested this variant was probably pathogenic by altering the three-dimensional structure of GLA protein. AC16 cardiomyocytes overexpressing wild-type and mutant GLA were constructed via lentiviral vectors. Immunofluorescence staining revealed that the intracellular localisation of the mutant protein remained unaltered, whereas \u03b1-Gal A enzyme activity was significantly reduced. Treatment with migalastat, a pharmacological chaperone for \u03b1-Gal A, partially restored the mutant \u03b1-Gal A enzymatic activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study identified\n                      <jats:italic>GLA<\/jats:italic>\n                      c.227T&gt;A (p.Met76Lys) as a novel pathogenic variant that primarily causes cardiac dysfunction. Migalastat may represent a therapeutic option for this variant.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2026-004016","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:15:30Z","timestamp":1779286530000},"page":"e004016","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Novel GLA variant in Fabry cardiomyopathy: evidence of pathogenicity and amenability to migalastat"],"prefix":"10.1136","volume":"13","author":[{"given":"Yingao","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3845-0002","authenticated-orcid":false,"given":"Fengnan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026052007152137000_13.1.e004016.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.07.010"},{"key":"2026052007152137000_13.1.e004016.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712309105"},{"key":"2026052007152137000_13.1.e004016.3","unstructured":"National Center for Biotechnology I . ClinVar: GLA (galactosidase alpha) gene. Available: https:\/\/www.ncbi.nlm.nih.gov\/clinvar?term=GLA%5Bgene%5D [Accessed 24 Sep 2025]."},{"key":"2026052007152137000_13.1.e004016.4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147663","article-title":"X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis","volume":"22","author":"Viggiano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026052007152137000_13.1.e004016.5","doi-asserted-by":"crossref","first-page":"C200","DOI":"10.1093\/eurheartjsupp\/suad045","article-title":"Cardiac magnetic resonance in Fabry disease","volume":"25","author":"Lanzillo","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"2026052007152137000_13.1.e004016.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.03.020"},{"key":"2026052007152137000_13.1.e004016.7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ehjci\/jeae021","article-title":"Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study","volume":"25","author":"Cotella","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026052007152137000_13.1.e004016.8","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.122"},{"key":"2026052007152137000_13.1.e004016.9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030956","article-title":"Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease","volume":"21","author":"Lukas","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026052007152137000_13.1.e004016.10","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026052007152137000_13.1.e004016.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"key":"2026052007152137000_13.1.e004016.12","first-page":"321","article-title":"Expert consensus for diagnosis and treatment of Fabry disease in China","volume":"60","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2026052007152137000_13.1.e004016.13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae270"},{"key":"2026052007152137000_13.1.e004016.14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cpdd.1","article-title":"Pharmacokinetics and Safety of Migalastat HCl and Effects on Agalsidase Activity in Healthy Volunteers","volume":"2","author":"Johnson","year":"2013","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2026052007152137000_13.1.e004016.15","doi-asserted-by":"publisher","DOI":"10.1126\/science.185.4154.862"},{"key":"2026052007152137000_13.1.e004016.16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jare.2025.03.023","article-title":"Pathogenicity of novel GLA gene missense mutations in Fabry disease and the therapeutic impact of migalastat","volume":"79","author":"Guo","year":"2026","journal-title":"J Adv Res"},{"key":"2026052007152137000_13.1.e004016.17","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur J Biochem"},{"key":"2026052007152137000_13.1.e004016.18","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313699"},{"key":"2026052007152137000_13.1.e004016.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm153"},{"key":"2026052007152137000_13.1.e004016.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02392-9","article-title":"Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry","volume":"17","author":"Beck","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2026052007152137000_13.1.e004016.21","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300364"},{"key":"2026052007152137000_13.1.e004016.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.01.035"},{"key":"2026052007152137000_13.1.e004016.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084267","article-title":"Comparative Study of Structural Changes Caused by Different Substitutions at the Same Residue on \u03b1-Galactosidase A","volume":"8","author":"Saito","year":"2013","journal-title":"PLoS ONE"},{"key":"2026052007152137000_13.1.e004016.24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000503998","article-title":"Functional Characterization and Pharmacological Evaluation of a Novel GLA Missense Mutation Found in a Severely Affected Fabry Disease Family","volume":"144","author":"Varela","year":"2020","journal-title":"Nephron"},{"key":"2026052007152137000_13.1.e004016.25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.5.1.277"},{"key":"2026052007152137000_13.1.e004016.26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2375com"},{"key":"2026052007152137000_13.1.e004016.27","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.220"},{"key":"2026052007152137000_13.1.e004016.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510198"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2026-004016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:15:33Z","timestamp":1779286533000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2026-004016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,20]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/openhrt-2026-004016"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2026-004016","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}